|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depletion, depreciation and accretion | |||||
| Deferred income tax provision (benefit) | |||||
| Impairment of contract asset | |||||
| Asset impairment | |||||
| Stock-based compensation, net | |||||
| Unrealized gain on derivative contracts | |||||
| Amortization/accretion of financing related costs | |||||
| Loss on extinguishment of debt | |||||
| Accrued settlements on derivative contracts | |||||
| Change in fair value of embedded derivative liability | |||||
| Other expense | |||||
| Change in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaids and other | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Oil and natural gas capital expenditures | |||||
| Proceeds received from sales of oil and natural gas assets | |||||
| Acquisition of oil and natural gas properties | |||||
| Other operating property and equipment capital expenditures | |||||
| Contract asset | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings | |||||
| Repayments of borrowings | |||||
| Payment of deferred financing costs | |||||
| Proceeds from issuance of preferred stock | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Disclosure of non-cash investing and financing activities: | |||||
| Asset retirement obligations | |||||
| Accrued capital expenditures | |||||
| Capital expenditures in accrued liabilities and accounts payable | |||||
| Contract asset costs in accounts payable and accrued liabilities | |||||
| Deemed dividends on Series A preferred stock | |||||
| Accrued offering costs | |||||
Loading...